Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 413-910-1 | CAS number: 1467668-33-2 LUPEROX 610-E-35; LUPEROX 610-E-50; LUPEROX 610-EN-50; LUPEROX 610-M-50; LUPERSOL 610; LUPERSOL 610-M-50
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline No. 408, 21 September 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of method:
- in vivo
Test material
- Reference substance name:
- 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate
- EC Number:
- 413-910-1
- EC Name:
- 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate
- Cas Number:
- 1467668-33-2
- Molecular formula:
- C16H32O4
- IUPAC Name:
- 4-hydroxy-2-methylpentan-2-yl 2-ethyl-2-methylheptaneperoxoate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Vehicle:
- corn oil
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 7 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10, 100 and 300 mg/kg bw/day
Basis:
actual ingested
the dose-levels are expressed in terms of the active material (3 hydroxy 1,1 dimethylbutyl peroxyneodecanoate) and correspond to the doses of 11.12, 111.2 and 333.6 mg Luperox 610/kg/day, respectively, taking into account the correction factor of 1.112
- No. of animals per sex per dose:
- 16 (control and 1000 mg/kg bw/d)
10 (10 and 100 mg/kg bw/d) - Control animals:
- yes, concurrent vehicle
- Details on study design:
- Monitoring of estrous cycle
The estrous cycle stage was determined for each female planned to be sacrificed at the end of the treatment period, from a fresh vaginal lavage (stained with methylene blue), daily for 21 consecutive days before the end of the treatment period.
As no treatment-related changes were observed at the end of the treatment period, these examinations were not carried out at the end of the treatment-free period.
SEMINOLOGY
At the end of the treatment period, just before sacrifice, each male was deeply anesthetized by an intraperitoneal injection of sodium pentobarbital and the left epididymis was removed. Animals were then sacrificed.
As no treatment-related changes were observed at the end of the treatment period, these examinations were not carried out at the end of the treatment-free period.
- Epididymal sperm
Sperm from the cauda epididymis was sampled for motility and morphology investigations (see § Epididymal sperm motility, and § Epididymal sperm morphology).
The cauda of the left epididymis was separated from the corpus using a scalpel and subsequently kept at 20°C pending further investigation (see § Epididymal sperm count).
- Epididymal sperm motility
The sperm was evaluated on a slide, after appropriate dilution. The number of motile and immotile spermatozoa from a sample of 200 spermatozoa was evaluated under a microscope using a 40-fold magnification. Results were expressed as the proportion of motile and non-motile spermatozoa.
- Epididymal sperm morphology
The morphology was determined from a sperm smear, after eosin staining and counting of 100 spermatozoa per slide. Results were expressed as the proportion of spermatozoa in each of the following categories:
normal,
normally shaped head separated from flagellum,
abnormal head separated from flagellum,
abnormal head with normal flagellum,
abnormal head with abnormal flagellum,
normally shaped head with abnormal flagellum.
- Epididymal sperm count
After thawing, the left cauda epididymis was weighed, minced and homogenized in a saline-triton solution using a Polytron.
An aliquot of the suspension was sampled and the number of spermatozoa was counted in a microscope slide counting chamber.
Results were expressed as the number of spermatozoa per cauda and per gram of cauda.
- Testicular sperm
At necropsy, the left testis was sampled and frozen at -20°C for further sperm count investigation. After thawing, the left testis was weighed (without the albuginea) and ground. The resulting preparation was diluted and sperm heads resistant to homogeneization (i.e. elongated spermatids and mature spermatozoa) were counted in a microscope slide counting chamber.
Results were expressed as a number of sperm heads per gram of testis and the daily sperm production rate was calculated (using a time divisor of 6.10; Blazak et al., 1993).
- Organ weights
Right and left epididymides, ovaries, right and left testes and uterus were weighed wet as soon as possible after dissection.
- Microscopic examination
A microscopic examination was performed on: right epididymides, mammary glands/area, ovaries (including oviducts), prostate (dorso-lateral and ventral), seminal vesicles (including coagulation gland), right testes, uterus (horns and cervix) and vagina for the control and high-dose animals (groups 1 and 4) sacrificed at the end of the treatment period and for animal found dead,
In addition testicular staging was performed for control and high-dose males (groups 1 and 4). A detailed examination of the testes was performed, using a thorough understanding of tubule development through the different stages of the spermatogenic cycle. Transverse sections of the testes were stained with hematoxylin: PAS in order to detect retained spermatids, missing germ cell layers, multinucleated giant cells or sloughing of spermatogenic cells into the lumen, etc.
Results and discussion
Effect levels
- Dose descriptor:
- NOAEL
- Remarks:
- Reproductive organs
- Effect level:
- > 300 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level:
- other: No effects were observed
Observed effects
No effects were observed on the estrous cycle.
- Seminology
No test item-related effects were noted at seminology investigations.
- Organ weights
No test item-related effects were noted.
- Microscopic examination
No test item-related effects were noted.
Any other information on results incl. tables
Mean sperm analysis data
Sex |
Male |
|||
Dose-level (mg/kg/day) |
0 |
10 |
100 |
300 |
% of motile sperm |
98.1 |
98.2 |
97.6 |
94.4 |
% of morphologically normal sperm |
96.0 |
96.7 |
95.6 |
93.9 |
Mean number of spermatozoa |
165.9 |
183.7 |
150.5 |
171.9 |
Mean number of sperm heads |
123.7 |
117.3 |
109.0 |
110.5 |
Applicant's summary and conclusion
- Executive summary:
In the frame of the OECD 408 study (Haag, 2015), the estrous cycle was determined on all females daily for 21 consecutive days at the end of the treatment period. Seminology investigations (count, motility and morphology) were performed on all males at time of sacrifice at the end of the treatment period. Histopathological examinations of the male and female reproductive organs were performed on control and 300 mg/kg bw/day groups at time of sacrifice. No effects were observed on these reproductive parameters.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.